Indications & Dose:
Type 2 diabetes mellitus as monotherapy (if metformin inappropriate), or in combination with metformin or a sulfonylurea (if metformin inappropriate), or pioglitazone (when treatment with either metformin or a sulfonylurea or pioglitazone fails to achieve adequate glycaemic control), and also in combination with both metformin and a sulfonylurea (when dual therapy with these drugs fails to achieve adequate glycaemic control) | Type 2 diabetes mellitus in combination with insulin (with or without metformin) when a stable dose of insulin has not provided adequate glycaemic control
BY MOUTH Adult: 5 mg once daily
Contraindications:
history of serious hypersensitivity to Dipeptidyl peptidase-4inhibitor
Side Effects:
Cautions:
Elderly determine renal function before treatment and priodically thereafter; discontinue if symptoms of acute pancreatitis ocur. HEPATIC IMPAIRMENT: Use with caution in moderate impairment; avoid severe impairment.
RENAL IMPAIRMENT:Reduce dose 2.5mg once daily in moderate to severe impairment, avoid in severe
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Vomiting, dyspepsia, gastritis, peripheral oedema, headache, dizziness, fatigue, upper respiratory tract infection, gastroenteritis, UTI, sinusitis, nasopharyngitis, hypoglycemia, myalgia, . Less rarely: dyslipidemia, hypertriglyceridaemia, pancreatitis, erectile dysfunction, oral reported rash.
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team